Clinical Trials Update: Feb. 20, 2007
1816
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
383170
Human Genome Sciences, Inc. announced today that it has begun dosing patients in a Phase 2 clinical trial of HGS-ETR1 (agonistic human monoclonal antibody to TRAIL Receptor 1) in patients with advanced ...
122956
Many clinical cancer trials are not published in order to keep industry secrets. A British cancer research group calls for all studies to be published -- even those with marginal results -- so doctors are not misled.
730173
TORONTO - Some of the world&#39;s most prestigious medical journals have banded together to force pharmaceutical and medical device companies to report the full results of clinical trials, both positive and negative.
320923
ASK YOUR DOCTOR ABOUT VIOXX . . . but not for the reasons Merck &amp; Co. recommends. Last week a Food and Drug Administration (FDA) study found a link with heart attacks, and several large health insurers said
271953
In a recent trial, a pain medication wasn't as effective as had been hoped.
269165
A pivotal trial for lead drug, Ranexa, is nearing completion and results will be released in the first quarter of 2007.
470908
Six months after the drug industry vowed to make its clinical trials more transparent, and three months after launching a common website to give the public "unprecedented access" to studies both good and bad, drug companies have posted unpublished trial results on the site for just five drugs.
95097
NEW YORK -- The pharmaceutical industry yesterday said it plans to publish more data about clinical drug trials, despite skepticism about whether the initiative will increase transparency and improve drug safety.
240625
Pfizer Inc. said on Monday it plans to sponsor a major clinical study to further assess the cardiovascular safety of its arthritis drug Celebrex following the withdrawal of Merck & Co.'s Vioxx, a drug in the same class.
181893
The U.S. Food and Drug  Administration on Thursday ordered the review of preventative  studies involving Pfizer Inc.'s painkillers Celebrex and  Bextra, in light of recent evidence they may increase the risk  of heart attack and stroke.
424951
NEW YORK - A new round of trials have shown a boosted risk of heart problems among patients taking the painkiller Celebrex, manufacturer Pfizer Inc.
500493
SATURDAY, Jan. 29 (HealthDayNews) -- A new drug that targets pancreatic cancer in two ways is being tested by oncologists at the University of Southern California/Norris Comprehensive Cancer Center.
501444
The Food and Drug Administration has approved a new drug for multiple sclerosis that in clinical trials got better results than existing drugs in protecting against relapses.
520613
British researchers are set to begin human trials of a vaccine for type 1 diabetes, BBC News Online reported Monday. Seventy-two diabetic patients are set to participate in the studies beginning next spring
390422
FRIDAY, Nov. 17 (HealthDay News) -- Just-released data from a trial that was stopped early in 2004 for safety reasons is re-igniting debate on the safety of two popular painkillers.
370649
The Food and Drug Administration will examine clinical trial data for thousands of depressed adults to see if they, like children, suffered increased suicidal thoughts and behaviors while taking antidepressants.    Dr...